Blenrep
For appropriate patients faced with relapsed/ refractory multiple myeloma. BLEEP is the first and only
BCMA-targeted ADC monotherapy. So you can offer your RRMM patients a different option.
“FORGE AHEAD
WITH A BOLD APPROACH”
